Wolfgang Miesbach: Jan Astermark at the BIC 2025 Presented Potentially the First Oral FVIII Mimetic Treatment for Hemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on Linkedin:
”For decades, oral protein delivery has failed.
Jan Astermark at the BIC meeting 2025 presented comprehensive information on oral factor VIII bispecific treatment for haemophilia A – potentially the first oral FVIII mimetic treatment!
Why is this so groundbreaking?
For decades, oral protein delivery has failed due to three major barriers:
- Large molecular size (poor absorption/bioavailability)
- GI instability (narrow pH tolerance, variable factors)
- High hydrophilicity (can’t cross membrane barriers)
This innovative Inno8 approach systematically addresses each challenge: ✨
- Optimized size (~30 kDa) via albumin binding technology
- Enhanced stability through protraction and pH optimization
- SNAC absorption enhancement for membrane permeability
- Extended half-life (115h terminal half-life!)
- Once-daily dosing potential with reduced variability
Inno8 successfully balances all critical aspects for an oral hemophilia drug – Size ✓ Potency ✓Stability ✓ PK ✓ – currently advancing through Phase 1 clinical trials for both patients with and without inhibitors.”
Stay updated on all coming congresses and seminars in the field of bleeding disorders with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator